Engineering neuroblastoma models for clinical translation
Neuroblastoma is a profoundly heterogenous extracranial solid tumor in pediatric patients. Elevated risk grade of neuroblastoma has been correlated with unsatisfactory prognosis and resistance to chemotherapy. Despite multimodal therapies exploited for killing neuroblastoma tumor cells, in high-risk...
Saved in:
| Main Authors: | Taiyu Song, Rui Liu, Feika Bian, Bin Kong, Jingjing Gan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-01-01
|
| Series: | Engineered Regeneration |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666138125000088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomes and immune modulation: implications for neuroblastoma immunotherapy
by: Martina Morini, et al.
Published: (2025-05-01) -
POSTTREATMENT NEUROBLASTOMA MATURATION TO GANGLIONIC CELL TUMOR
by: M. V. Ryzhova, et al.
Published: (2015-04-01) -
Circulating tumor cells and clusters as liquid biomarkers for the diagnosis and prognosis of neuroblastoma
by: Huanli Xu, et al.
Published: (2025-07-01) -
Neuroblastoma presenting as haemophagocytic lymphohistiocytosis
by: Monika Pogorzala
Published: (2025-04-01) -
Role and practical guidelines for the use of radiotherapy in neuroblastoma — a narrative review of literature and clinical trial protocols
by: Aleksandra Jadwiga Sztuder, et al.
Published: (2025-01-01)